Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.
NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1134-42.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Cyclooxygenase 2 Inhibitors
Drug Recalls
Female
Hospitalization
Humans
Lactones
Male
Middle Aged
Peptic Ulcer
Proton Pump Inhibitors
Safety-Based Drug Withdrawals
Sulfones
Young Adult
authors with profiles
Robert James Glynn, Sc.D., Ph.D.
Sebastian Schneeweiss, Sc.D., M.D.
Jerome Lewis Avorn, M.D.
Daniel Hal Solomon, M.D.